Methylene blue has had two parallel lives. In medicine, it’s a 130-year-old drug — used for malaria, methemoglobinemia (a serious blood disorder), and some surgical applications. In the wellness market, it’s a recent viral fad — sold as drops on TikTok with claims about cognition, longevity, mitochondrial enhancement, and Alzheimer’s prevention.
The medical story is solid. The wellness story is much more mixed than the marketing suggests, with real safety considerations that don’t show up in 60-second clips.
Here’s a clear, evidence-grounded guide to what methylene blue is, what it’s actually been shown to do, and what to be cautious about.
Lose weight
Gain muscles
Eat healthy
Explore new cuisines
James W.
Available on the App StoreWhat methylene blue is
Methylene blue is a synthetic dye — first synthesized in 1876 — that turned out to have biological activity. Chemically it’s a phenothiazine derivative; pharmacologically it’s an electron-shuttling redox agent that interacts with mitochondrial electron transport.
It’s bright blue when oxidized and turns colorless when reduced. The color shift is part of its chemistry — and part of why it’s been used as a dye in microbiology and surgery.
Established medical uses (FDA-approved or standard practice)
Where methylene blue genuinely works:
Methemoglobinemia
The classic medical use. Methemoglobin is a form of hemoglobin that can’t carry oxygen efficiently. Severe methemoglobinemia is a medical emergency. IV methylene blue (1–2 mg/kg) reduces methemoglobin back to functional hemoglobin.1 FDA-approved use.
Cyanide poisoning (historical/limited use)
Used as part of the antidote regimen. Less common now with newer antidotes.
Surgical mapping
Used as a dye in parathyroid and lymph node surgery to identify tissue.
Malaria treatment (historical)
The original anti-malarial drug. Replaced by more effective options.
Septic shock (research/off-label)
Studied for refractory vasoplegia — when blood pressure won’t respond to standard treatment in shock.
The wellness claims and what evidence supports them
The viral wellness market makes claims about:
Cognition and memory
The mechanism is plausible: methylene blue affects mitochondrial function and has been studied at low doses for cognitive effects. A 2021 animal study showed methylene blue improved memory in rats with hepatic encephalopathy.2 Earlier human imaging studies have shown improved short-term memory and changes in brain activation patterns.
But:
- Human RCT data in healthy adults is limited
- Effects in clinical populations (e.g., Alzheimer’s) have been mixed in trials
- The dose ranges studied (typically very low, 0.5–4 mg/kg) are different from what’s sold in wellness drops
Mitochondrial function
Mechanistically real — methylene blue can shuttle electrons in cellular respiration, potentially supporting mitochondrial efficiency. Whether this translates to subjective benefits at the doses people actually take is unclear.
Anti-aging
Animal data on cellular health is interesting. Human longevity data doesn’t exist.
Alzheimer’s prevention
A specific methylene blue derivative (LMTM, hydromethylthionine) was tested in late-stage Alzheimer’s trials. Results were equivocal — the trials largely missed primary endpoints, though some signals appeared in subgroup analyses. This is not the same as buying methylene blue drops on Instagram.
The serious safety concern most users don’t know about
The single most important methylene blue fact: it’s a potent monoamine oxidase inhibitor (MAOI) at standard doses.
A 2010 review found that even relatively low IV doses (1 mg/kg) produced central nervous system effects, with 13 of 14 reported cases of CNS toxicity meeting clinical criteria for serotonin syndrome.3 The mechanism: methylene blue inhibits MAO-A, causing serotonin buildup when combined with serotonin reuptake inhibitors.
Serotonin syndrome can be life-threatening. Symptoms include:
- Mental status changes (agitation, confusion, hallucinations)
- Autonomic instability (high heart rate, blood pressure swings, sweating)
- Neuromuscular symptoms (tremor, hyperreflexia, rigidity)
- Severe cases: hyperthermia, seizures, death
Methylene blue should not be combined with:
- SSRIs (Prozac, Zoloft, Lexapro, Paxil, Celexa, etc.)
- SNRIs (Effexor, Cymbalta, Pristiq)
- MAOIs
- Tramadol
- Triptans (for migraines)
- Many other serotonergic medications
This is a real, FDA-warned interaction. The wellness market mostly doesn’t communicate this clearly. Anyone on antidepressants who buys methylene blue from a TikTok shop is taking a meaningful risk.
For a deeper safety walkthrough, see is methylene blue safe and methylene blue side effects.
Suggested read: Methylene Blue Dosage: Safe Doses by Use Case
Pharmaceutical-grade vs. wellness products
Another big issue: the methylene blue sold in pharmacies is FDA-approved, manufactured under quality controls, and used in clinical settings. The methylene blue sold in wellness markets often is not.
Concerns with wellness-grade methylene blue:
- Industrial-grade or aquarium-grade methylene blue contains heavy metal contaminants (zinc, copper, etc.) and shouldn’t be ingested
- Some products labeled “USP” methylene blue have varying purity
- Concentration accuracy is variable
- Contamination testing is not standardized
If you’re going to take methylene blue, only pharmaceutical-grade USP-certified methylene blue is appropriate for human use.
How wellness users are taking it
Common patterns (not endorsements):
- Sublingual drops: typical “wellness” doses are 1–10 mg taken sublingually
- Combined with light therapy: some claims about photobiomodulation synergy
- Combined with red light: similar claims
- In combination with nicotinic acid, B vitamins, etc.
Doses used in clinical trials for cognition were typically 1–4 mg/kg — meaning 70–280 mg for a 70 kg adult. Wellness doses (1–10 mg) are 10–100 times lower.
The supplements may be too low to do much (placebo dominant) or, if from contaminated sources, dangerous.
Suggested read: NAD+: What It Is, How It Works, and Supplement Evidence
Common questions
Is methylene blue safe for healthy adults? At low pharmaceutical-grade doses, generally yes for healthy adults not on contraindicated medications. The drug interactions are the main concern.
Will it stain my mouth blue? Yes. It’s a dye. Tongue, lips, urine, and stool can turn blue or green for hours.
Can it cure Alzheimer’s? No. The methylene blue derivative LMTM was tested in late-stage Alzheimer’s; results were equivocal at best. Pharmaceutical-grade methylene blue itself isn’t an approved Alzheimer’s treatment.
Is it the same as the methylene blue used to treat fish? No. Aquarium-grade methylene blue contains contaminants and shouldn’t be ingested.
Will it help my mitochondrial function? Mechanistically plausible. Whether this translates to noticeable subjective effects is unclear.
Can I take it daily? Long-term safety data in healthy adults at wellness doses is limited. Avoid daily use without medical supervision.
Who should completely avoid methylene blue
- Anyone on SSRIs, SNRIs, MAOIs, or other serotonergic medications
- People with G6PD deficiency (a genetic enzyme deficiency; methylene blue can cause severe hemolysis)
- Pregnant or breastfeeding women
- People with severe liver or kidney disease without medical guidance
- Children
- People who can’t verify they’re getting pharmaceutical-grade material
Bottom line
Methylene blue is an established pharmaceutical with real medical uses, particularly for methemoglobinemia. The wellness market has overhyped its benefits and mostly underplayed its safety profile — particularly the MAOI activity that creates real risk in combination with common antidepressants. If you’re considering it: only use pharmaceutical-grade USP-certified material, only at low doses, only if you’re not on serotonergic medications, and ideally with medical guidance. The viral wellness version of methylene blue isn’t the same product as the pharmaceutical version, and the gap matters.
Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol. 2011;25(3):429-36. PubMed ↩︎
Méndez M, Fidalgo C, Arias JL, Arias N. Methylene blue and photobiomodulation recover cognitive impairment in hepatic encephalopathy through different effects on cytochrome c-oxidase. Behav Brain Res. 2021;403:113164. PubMed ↩︎
Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol. 2011;25(3):429-36. PubMed ↩︎
Sarah M.
Linda P.
Maya T.
Marcus J.
Emma R.
Amanda K.
Chris B.
David L.
James W.
Jennifer S.
Kevin H.
Lisa C.
App Store ★★★★★
